Results 71 to 80 of about 278,909 (163)

Features of Carbapenem-resistant Gram-negative Bacterial Infections in Japan Based on the Setting of Onset. [PDF]

Open Forum Infect Dis
Kawamoto Y, Asai Y, Sakurai A, Matsumura Y, Hase R, Kato H, Matono T, Itoh N, Hashimoto T, Yamamoto G, Mawatari M, Tsutsumi T, Suzuki T, Tsuzuki S, Ohyama K, Suzuki M, Hayakawa K, Uemura K, van Duin D, Ohmagari N, Doi Y, Saito S.   +21 more
europepmc   +1 more source

Status of Antibiotic Susceptibility of Polymyxin B And Colistin in the Treatment of Carbapenem Resistant Gram Negative Bacterial Infections: An Observational Study. [PDF]

JNMA J Nepal Med Assoc
Bhattarai AK, Pokharel K, Shrestha MV.
europepmc   +1 more source

New Frontiers for Old Medications: Repurposing Approved Drugs Against Gram-Negative Bacterial Infections. [PDF]

Microorganisms
Aloni-Grinstein R, Mamroud E, Gal Y.
europepmc   +1 more source

Factors affecting the effectiveness and safety of colistin in treating drug-resistant gram-negative bacterial infections: a meta-analysis. [PDF]

Front Pharmacol
Li P, Li S, Zhang J, Zeng S, Li Z, Xie J, Yang Y.   +6 more
europepmc   +1 more source

Colistin-based combination therapy versus monotherapy for carbapenem-resistant gram-negative bacterial infections: a systematic review and meta-analysis. [PDF]

Front Cell Infect Microbiol
Yang T, Li H, Xu X, An J, Zhang Z, Li B, Dou Z.   +6 more
europepmc   +1 more source

Bedside Risk Scoring for Carbapenem-Resistant Gram-Negative Bacterial Infections in Patients with Hematological Malignancies. [PDF]

Infect Dis Rep
Başağa SM, Ulu Kılıç A, Ture Z, Zararsız G, Yerlitaş Sİ.   +4 more
europepmc   +1 more source

Antibiotic Therapy Duration for Multidrug-Resistant Gram-Negative Bacterial Infections: An Evidence-Based Review. [PDF]

Int J Mol Sci
Marino A, Augello E, Bellanca CM, Cosentino F, Stracquadanio S, La Via L, Maniaci A, Spampinato S, Fadda P, Cantarella G, Bernardini R, Cacopardo B, Nunnari G.   +12 more
europepmc   +1 more source

Efficacy and safety of ceftazidime-avibactam versus standard antibiotic therapy for resistant Gram-negative bacterial infections: a systematic review and meta-analysis. [PDF]

J Thorac Dis
Li J, Dong Z, Tang L, Liu L, Yu S.
europepmc   +1 more source

A Comparative Study of Ceftazidime-Avibactam and Meropenem-Based Regimens in the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections in Intensive Care Units. [PDF]

Antibiotics (Basel)
Aydın M, Aydın NN, Aslan MH, Kahramanoğlu M.   +3 more
europepmc   +1 more source

Harnessing endogenous anti-glycan antibodies using a novel, bifunctional immunotherapy to treat gram-negative bacterial infections. [PDF]

J Immunol
Hairsine B, Leire E, Rostam HM, Kristian SA, Rhodes E, Johnson A, Bushdyhan M, Chapman D, Pickford C, Westby M, Bright H.   +10 more
europepmc   +1 more source